AIRO (AIRO) Q2 2026 Earnings Call Transcript

AIRO Group reported Q2 revenue of $43.2M (+76% YoY) with gross margin rising to 64% (from 61% YoY), and swung to operating income of $1.7M vs a $19.7M operating loss a year ago. The company reiterated FY revenue growth of 15%-25% and guided full-year adjusted EBITDA to the negative mid-to-high teens millions, while expecting $163M drone backlog (up 9% sequentially) to convert to revenue within 12 months. Liquidity improved materially with cash increasing to ~$56M by July 31 (from $25.9M on June 30). Operationally, Blue UAS certification for the RQ-35 and rollout/production plans for the RQ-70 (production start expected January 2027) support a clearer path to U.S. defense procurement despite ongoing geopolitical/regulatory permitting friction in Ukraine affecting joint ventures.

Analysis

AIRO looks like a classic “good quarter, bad stock setup” name: the operating inflection is real, but the market may be pricing the certification and margin step-up as if they translate into near-term U.S. contract flow. The bigger mechanism is that Blue UAS changes the probability distribution, not the earnings math; revenue still depends on procurement timing, and the company itself signaled a softer sequential quarter before a better Q4. That creates a window where the stock can give back gains if investors extrapolate the quarter too aggressively.

The second-order winner is AIRO’s domestic defense channel, but the real follow-on benefit may show up in working capital and bargaining power: a more credible U.S. pipeline should reduce receivable concentration and improve supplier terms as scale becomes visible. The losers are the capital-intensive training assets and, to a lesser extent, any non-core avionics spend that competes for management attention. The strategic-alternatives process matters more as a capital-allocation signal than as a near-term valuation catalyst.

Contrarian view: consensus may be underestimating how much backlog quality matters versus headline backlog size. A large portion converting within 12 months is helpful, but the market should discount anything not yet tied to U.S. procurement channels; the real test is whether U.S. orders appear in backlog by the next two quarters. Falsifiers are simple: no U.S. backlog recognition, another sequential revenue drop beyond guidance, or continued training underperformance forcing more investment instead of a divestiture.

The cleaner long-term thesis is 2027, not 2026: if RQ-70 production starts on time and the cargo/ISR platforms keep tracking below budget, AIRO could exit next year with a much better mix and less volatility. Until then, this is more of a catalyst-trading name than a fundamental compounder, and liquidity/volatility should stay high.

Key Decisions for Investors

• Short-term: buy AIRO only on a post-earnings pullback or if it fades after the initial certification pop; use a 1-3 month horizon and treat the trade as a catalyst bet on U.S. backlog recognition, not on headline growth.
• Conditional pair trade: long AIRO / short AVAV or KTOS on a relative basis if AIRO begins booking U.S. orders, because the market will likely re-rate the smaller name faster on incremental backlog inflection; exit if AIRO fails to add U.S. backlog by the next two quarters.
• Avoid chasing the move if the stock is already discounting 2027 production success; the upside is capped until there is independent evidence of procurement conversion, so wait for backlog disclosure or a guidance raise before adding size.
• Watch item: if Q3 revenue comes in below the sequential guidance path or the training segment worsens, reassess the long thesis immediately; that would imply the current rally is ahead of the fundamentals.